You guys still do not get it. The Moly mine is mostly unprofitable at the current Molybdenum price. That is why the market has priced MOL where it is.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025